In our Decade Award-winning article from 2012, we theorized and provided evidence consistent with nation-level institutions ... In this Retrospective, we briefly discuss our original findings and ...
The goal of the partnership is to provide evidence-based, non-commercial clinical reviews coupled with academic analysis of drug utilization to improve safe and cost-effective use of medications in ...
In a 12-month period before and after erenumab use, patients with chronic migraine decreased HRU and use of acute and traditional migraine preventive medications.